{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T21:55:57Z","timestamp":1762898157284},"reference-count":35,"publisher":"Elsevier BV","issue":"13","license":[{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2006,3]]},"DOI":"10.1016\/j.vaccine.2005.11.058","type":"journal-article","created":{"date-parts":[[2005,12,15]],"date-time":"2005-12-15T20:38:49Z","timestamp":1134679129000},"page":"2409-2416","source":"Crossref","is-referenced-by-count":24,"title":["Co-administration of IL-12 DNA with rORFF antigen confers long-term protective immunity against experimental visceral leishmaniaisis"],"prefix":"10.1016","volume":"24","author":[{"given":"Poonam","family":"Tewary","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shailendra","family":"Saxena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rentala","family":"Madhubala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2005.11.058_bib1","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S0140-6736(98)10178-2","article-title":"Leishmaniasis","volume":"354","author":"Herwaldt","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2005.11.058_bib2","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1146\/annurev.iy.13.040195.001055","article-title":"The regulation of immunity to Leishmania major","volume":"13","author":"Reiner","year":"1995","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.vaccine.2005.11.058_bib3","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1159\/000058698","article-title":"Experimental cutaneous leishmaniasis: induction and regulation of T cells following infection of mice with Leishmania major","volume":"70","author":"Scott","year":"1998","journal-title":"Chem Immunol"},{"key":"10.1016\/j.vaccine.2005.11.058_bib4","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.4049\/jimmunol.146.8.2763","article-title":"Differential production of Th1- and Th2-derived cytokines does not determine the genetically controlled or vaccine-induced rate of cure in murine visceral leishmaniasis","volume":"146","author":"Kaye","year":"1991","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2005.11.058_bib5","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1128\/IAI.62.3.1058-1063.1994","article-title":"Th1 and Th2 cell-associated cytokines in experimental visceral leishmaniasis","volume":"62","author":"Miralles","year":"1994","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2005.11.058_bib6","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.4049\/jimmunol.156.6.2231","article-title":"Local suppression of IFN-gamma in hepatic granulomas correlates with tissue-specific replication of Leishmania chagasi","volume":"156","author":"Wilson","year":"1996","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2005.11.058_bib7","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1086\/516482","article-title":"Endogenous interleukin-12 regulates acquired resistance in experimental visceral leishmaniasis","volume":"175","author":"Murray","year":"1997","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2005.11.058_bib8","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1126\/science.8097338","article-title":"Development of Th1 CD41 T cells through IL-12 produced by Listeria-induced macrophages","volume":"260","author":"Hsieh","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2005.11.058_bib9","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1084\/jem.177.4.1199","article-title":"Natural killer cell stimulatory factor interleukin-12 (IL-12) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells","volume":"177","author":"Manetti","year":"1993","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2005.11.058_bib10","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1084\/jem.179.4.1273","article-title":"Interleukin-12 induces stable priming for interferon \u03b3 (IFN-\u03b3) production during differentiation of human T helper (Th) cells and transient IFN-\u03b3 production in established Th2 cell clones","volume":"179","author":"Manetti","year":"1994","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2005.11.058_bib11","doi-asserted-by":"crossref","first-page":"10188","DOI":"10.1073\/pnas.90.21.10188","article-title":"Interleukin-12 acts directly on CD4+ T cells to enhance priming for interferon \u03d2 production and diminishes interleukin-4 inhibition of such priming","volume":"90","author":"Seder","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2005.11.058_bib12","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.4049\/jimmunol.151.4.1938","article-title":"IL-12 induces the production of IFN-g by neonatal human CD4 T cells","volume":"151","author":"Wu","year":"1993","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2005.11.058_bib13","doi-asserted-by":"crossref","first-page":"730","DOI":"10.4049\/jimmunol.155.2.730","article-title":"Endogenous IL-12 is required for the control of Th2 cytokine responses capable of exacerbating Leishmaniasis in normally resistant mice","volume":"155","author":"Heinzal","year":"1995","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2005.11.058_bib14","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1002\/eji.1830260722","article-title":"Genetically resistant mice lacking interleukin-12 are susceptible to infection with L. major and mount polarized Th2 responses","volume":"26","author":"Mattner","year":"1996","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2005.11.058_bib15","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0952-7915(98)80121-0","article-title":"Regulation of protective immunity against Leishmania major in mice","volume":"10","author":"Louis","year":"1998","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.vaccine.2005.11.058_bib16","first-page":"783","article-title":"Resolution of cutaneous leishmaniasis: interleukin-12 initiates a protective T helper type 1 immune response","volume":"180","author":"Sypek","year":"1993","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2005.11.058_bib17","first-page":"1627","article-title":"Interleukin-12 is effective treatment for an established systemic intracellular infection: experimental visceral leishmaniasis","volume":"70","author":"Murray","year":"1995","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2005.11.058_bib18","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1006\/expr.1999.4453","article-title":"Leishmania donovani: characterization and expression of ORFF, a gene amplified from the LD1 locus","volume":"93","author":"Ghosh","year":"1999","journal-title":"Exp Parasitol"},{"key":"10.1016\/j.vaccine.2005.11.058_bib19","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0378-1119(94)90688-2","article-title":"A frequently amplified region in Leishmania contains a gene that is conserved in prokaryotes and eukaryotes","volume":"148","author":"Myler","year":"1994","journal-title":"Gene"},{"key":"10.1016\/j.vaccine.2005.11.058_bib20","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0166-6851(92)90125-4","article-title":"A multicopy, extrachromosomal DNA in Leishmania infantum contains two inverted repeats of the 27.5 kb LD1 sequence and encodes numerous transcripts","volume":"55","author":"Tripp","year":"1992","journal-title":"Mol Biochem Parasitol"},{"issue":"3","key":"10.1016\/j.vaccine.2005.11.058_bib21","doi-asserted-by":"crossref","first-page":"482","DOI":"10.4269\/ajtmh.1999.61.482","article-title":"Serodiagnosis of leishmaniasis with recombinant ORFF antigen","volume":"61","author":"Raj","year":"1999","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2005.11.058_bib22","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0264-410X(00)00207-3","article-title":"Immunization with recombinant LD1 antigens protects against experimental leishmaniasis","volume":"19","author":"Dole","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2005.11.058_bib23","doi-asserted-by":"crossref","first-page":"10984","DOI":"10.1073\/pnas.93.20.10984","article-title":"Regulation of the expression of nitric oxide synthase and leishmanicidal activity by glycoconjugates of Leishmania lipophosphoglycan in murine macrophages","volume":"93","author":"Proudfoot","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2005.11.058_bib24","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/S0264-410X(02)00352-3","article-title":"Vaccination with DNA encoding ORFF antigen confers protective immunity in mice infected with Leishmania donovani","volume":"21","author":"Sukumaran","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2005.11.058_bib25","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1016\/j.vaccine.2004.02.007","article-title":"Immunostimulatory oligodeoxynucleotides are potent enhancers of specific immunity in mice immunized with recombinant ORFF leishmanial antigen","volume":"22","author":"Tewary","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2005.11.058_bib26","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1084\/jem.177.5.1505","article-title":"Recombinant interleukin-12 cures mice infected with Leishmania major","volume":"177","author":"Heinzel","year":"1993","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2005.11.058_bib27","doi-asserted-by":"crossref","first-page":"5320","DOI":"10.4049\/jimmunol.154.10.5320","article-title":"IL-12 is required for natural killer cell activation and subsequent T helper 1 cell development in experimental leishmaniasis","volume":"154","author":"Scharton-Kersten","year":"1995","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2005.11.058_bib28","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1084\/jem.171.1.115","article-title":"Cure of murine leishmaniasis with anti-interleukin-4 monoclonal antibody. Evidence for a T cell-dependent, interferon-independent mechanism","volume":"171","author":"Sadick","year":"1990","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2005.11.058_bib29","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1126\/science.274.5286.421","article-title":"Resistance to Leishmania major induced by tolerance to a single antigen","volume":"274","author":"Julia","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2005.11.058_bib30","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1126\/science.7904381","article-title":"The adjuvant effect of interleukin-12 in a vaccine against Leishmania major","volume":"263","author":"Afonso","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2005.11.058_bib31","doi-asserted-by":"crossref","first-page":"8427","DOI":"10.1073\/pnas.160197797","article-title":"The role of antigen and IL-12 in sustaining Th1 memory cells in vivo: IL-12 is required to maintain memory\/effector Th1 cells sufficient to mediate protection to an infectious parasite challenge","volume":"97","author":"Stobie","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2005.11.058_bib32","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1038\/4000","article-title":"Vaccine requirements for sustained cellular immunity to an intracellular parasitic infection","volume":"4","author":"Gurunathan","year":"1998","journal-title":"Nat Med"},{"issue":"12","key":"10.1016\/j.vaccine.2005.11.058_bib33","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1086\/430348","article-title":"A heterologous prime boost vaccine regimen using ORFF DNA and recombinant ORFF protein confers protective immunity against experimental visceral leishmaniasis in murine mouse model","volume":"191","author":"Tewary","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2005.11.058_bib34","doi-asserted-by":"crossref","first-page":"870","DOI":"10.4049\/jimmunol.160.2.870","article-title":"CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen","volume":"160","author":"Davis","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2005.11.058_bib35","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.4049\/jimmunol.151.5.2511","article-title":"Modulation of perforin and granzyme messenger RNA expression in human natural killer cells","volume":"151","author":"Salcedo","year":"1993","journal-title":"J Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X05012089?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X05012089?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T19:44:01Z","timestamp":1706816641000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X05012089"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3]]},"references-count":35,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2006,3]]}},"alternative-id":["S0264410X05012089"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2005.11.058","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2006,3]]}}}